William Blair Downgrades CVS Caremark (CVS) to Market Perform
More News related to CVS
- MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast
- Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in CVS Caremark Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsui
- CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital
- Stull, Stull & Brody Announces Class Action on Behalf of Shareholders of CVS Caremark Corporation
- Shalov Stone Bonner & Rocco LLP Announces Class Action Against CVS Caremark Corporation
More News related to Downgrades
- Sign of the Times: U.S. Mint Has To Temporarily Suspend Sales of One Ounce Gold Coins Due to Demand
- Central Banks Continue Snapping Up Gold, Sri Lanka Buys 10 Metric Tons From IMF
- Holiday Retail Match-Up: Wal-Mart vs. Amazon... Who Will Come Out on Top?
- Research Firm Questions Surge In Origin Agritech (SEED)
- Starbucks (SBUX) Bets Big On China
William Blair downgrades CVS Caremark (NYSE: CVS) from Outperform to Market Perform.
To see more analyst ratings on CVS Click Here.
CVS Caremark Corporation, a pharmacy services company, provides prescriptions and related healthcare services in the United States.
Related Categories
DowngradesStocks Mentioned
-0.07Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
